Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × exemestane × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 25 Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Locoregional Recurrence 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Granulosa cell tumor of the ovary 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1 Advanced Breast Carcinoma 1 Acrocephalosyndactylia 1

Interventions

Specimen Handling 5 Tamoxifen 4 Standard of Care 4 Practice Guidelines as Topic 4 Methods 2 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Telemedicine 1 Starch 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Radiation 1 Observation 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Genotype 1 Gels 1 Educational Status 1 Early Intervention, Educational 1 Diet Therapy 1 Diet 1 Biopsy 1 Behavior Therapy 1 Anesthesia, General 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671912 2026-03-04

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡